Clinical Trial Results:
Prospective, multicenter study to evaluate the renal safety of
6 mg ibandronic acid infusions over 15 min or 60 min in patients with metastatic bone disease due to breast cancer.
Summary
|
|
EudraCT number |
2005-000535-18 |
Trial protocol |
DE |
Global completion date |
31 May 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 May 2022
|
First version publication date |
26 May 2022
|
Other versions |
|
Summary report(s) |
ML17632 Results statement |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.